M de Montalembert

Summary

Country: France

Publications

  1. ncbi request reprint Long-term hydroxyurea treatment in children with sickle cell disease: tolerance and clinical outcomes
    Mariane de Montalembert
    Service de Pediatrie Generale, Hopital Necker, Paris, France
    Haematologica 91:125-8. 2006
  2. pmc Preliminary report of a toxicity study of hydroxyurea in sickle cell disease. French Study Group on Sickle Cell Disease
    M de Montalembert
    Site Transfusionnel, Hopital Necker, 149 rue de Sevres, 75015 Paris, France
    Arch Dis Child 81:437-9. 1999
  3. ncbi request reprint Ethical aspects of neonatal screening for sickle cell disease in Western European countries
    Mariane de Montalembert
    Service de Pediatrie Generale, Hopital Necker Enfants Malades, Paris, France
    Acta Paediatr 94:528-30. 2005
  4. ncbi request reprint [Management of sickle cell disease]
    Mariane de Montalembert
    Service de Pediatrie Generale, Hopital Necker Enfants Malades, 75743 Paris Cedex 15
    Rev Prat 54:1557-64. 2004
  5. pmc Myocardial ischaemia in children with sickle cell disease
    M de Montalembert
    Service de Pediatrie Generale, Hopital Necker Enfants Malades, 149 rue de Sevres, 75015 Paris, France
    Arch Dis Child 89:359-62. 2004
  6. ncbi request reprint [Sickle cell disease in the neonatal period]
    M de Montalembert
    Service de Pediatrie Generale, Hopital Necker Enfants Malades, Paris
    J Gynecol Obstet Biol Reprod (Paris) 33:S12-4. 2004
  7. ncbi request reprint Antibiotic prevention of pneumococcal infections in asplenic hosts: admission of insufficiency
    M de Montalembert
    Service de Pediatrie Generale, Hopital Necker Enfants Malades, 149 rue de Sevres, 75015 Paris, France
    Ann Hematol 83:18-21. 2004
  8. ncbi request reprint [Management of children with sickle cell anemia: a collaborative work]
    M de Montalembert
    Service de Pediatrie Generale, Hopital Necker Enfants Malades, 149, rue de Sevres, 75015 Paris, France
    Arch Pediatr 9:1195-201. 2002
  9. ncbi request reprint [Is therapeutic progress in the management of sickle cell disease applicable in sub-Saharan Africa?]
    M de Montalembert
    Service de pédiatrie géndrale, Hopital Necker Enfants Malades, Paris, France
    Med Trop (Mars) 67:612-6. 2007
  10. doi request reprint [Hydroxyurea treatment in patients affected with sickle cell anemia: efficacy and safety]
    M de Montalembert
    Service de Pediatrie Generale, Hopital Necker Enfants Malades, 149, rue de Sevres, 75015 Paris, France
    Transfus Clin Biol 15:34-8. 2008

Detail Information

Publications12

  1. ncbi request reprint Long-term hydroxyurea treatment in children with sickle cell disease: tolerance and clinical outcomes
    Mariane de Montalembert
    Service de Pediatrie Generale, Hopital Necker, Paris, France
    Haematologica 91:125-8. 2006
    ..Treatment was also withdrawn in 5 of 6 children who had developed hypersplenism, in 3 because of a pathological transcranial Doppler, and in 2 after a stroke...
  2. pmc Preliminary report of a toxicity study of hydroxyurea in sickle cell disease. French Study Group on Sickle Cell Disease
    M de Montalembert
    Site Transfusionnel, Hopital Necker, 149 rue de Sevres, 75015 Paris, France
    Arch Dis Child 81:437-9. 1999
    ..To evaluate the tolerance of hydroxyurea in children affected with sickle cell disease...
  3. ncbi request reprint Ethical aspects of neonatal screening for sickle cell disease in Western European countries
    Mariane de Montalembert
    Service de Pediatrie Generale, Hopital Necker Enfants Malades, Paris, France
    Acta Paediatr 94:528-30. 2005
    ..As a result, links between the family and its original community are modified. Parents must more or less sever links with their family in Africa and try to trust and adapt to the public health services in Europe...
  4. ncbi request reprint [Management of sickle cell disease]
    Mariane de Montalembert
    Service de Pediatrie Generale, Hopital Necker Enfants Malades, 75743 Paris Cedex 15
    Rev Prat 54:1557-64. 2004
    ....
  5. pmc Myocardial ischaemia in children with sickle cell disease
    M de Montalembert
    Service de Pediatrie Generale, Hopital Necker Enfants Malades, 149 rue de Sevres, 75015 Paris, France
    Arch Dis Child 89:359-62. 2004
    ..The heart may be involved in children affected with sickle cell disease (SCD) via several mechanisms. Principally, chronic anaemia increases cardiac output and may cause left ventricular enlargement and cardiac insufficiency...
  6. ncbi request reprint [Sickle cell disease in the neonatal period]
    M de Montalembert
    Service de Pediatrie Generale, Hopital Necker Enfants Malades, Paris
    J Gynecol Obstet Biol Reprod (Paris) 33:S12-4. 2004
    ..A neonatal screening program, targeted with regard to the parents' ethnic background, has been implemented throughout metropolitan France since 1999. In 2002, this program enabled early diagnosis of sickle cell disease in 313 newborns...
  7. ncbi request reprint Antibiotic prevention of pneumococcal infections in asplenic hosts: admission of insufficiency
    M de Montalembert
    Service de Pediatrie Generale, Hopital Necker Enfants Malades, 149 rue de Sevres, 75015 Paris, France
    Ann Hematol 83:18-21. 2004
    ..Of the children with sickle cell disease, 48% were not receiving an antibiotic. This study demonstrates that risk of infections in asplenic patients is widely misunderstood, indicating the urgent need to improve their management...
  8. ncbi request reprint [Management of children with sickle cell anemia: a collaborative work]
    M de Montalembert
    Service de Pediatrie Generale, Hopital Necker Enfants Malades, 149, rue de Sevres, 75015 Paris, France
    Arch Pediatr 9:1195-201. 2002
    ....
  9. ncbi request reprint [Is therapeutic progress in the management of sickle cell disease applicable in sub-Saharan Africa?]
    M de Montalembert
    Service de pédiatrie géndrale, Hopital Necker Enfants Malades, Paris, France
    Med Trop (Mars) 67:612-6. 2007
    ..e., the only currently available curative treatment, is still possible only in northern hemisphere countries where it is still restricted to children with severe forms and an HLA-compatible family donor...
  10. doi request reprint [Hydroxyurea treatment in patients affected with sickle cell anemia: efficacy and safety]
    M de Montalembert
    Service de Pediatrie Generale, Hopital Necker Enfants Malades, 149, rue de Sevres, 75015 Paris, France
    Transfus Clin Biol 15:34-8. 2008
    ..Hydroxyurea has just been licensed for sickle cell adults and children in Europe. Its prescription for the moment must be restricted to severely affected patients, enrolled in long-term follow-up protocols...
  11. doi request reprint Osteopenia and vitamin D deficiency in children with sickle cell disease
    E Chapelon
    Pediatrie Generale, Hopital Jean Verdier, Paris, France
    Eur J Haematol 83:572-8. 2009
    ..To assess the prevalence in children with sickle cell disease of low bone mineral density (BMD), a feature found in up to 82% of adults but not well known in children...
  12. doi request reprint [Diagnosis of hypochromic microcytic anemia in children]
    M de Montalembert
    Service de Pediatrie Generale, Hopital Necker Enfants Malades, 149, rue de Sevres, 75015 Paris, France
    Arch Pediatr 19:295-304. 2012
    ..When iron stores are not replete at the end of treatment, compliance and dosage must be reevaluated and occult bleeding sought. The latter is also required when the iron store decreases 3 months after cessation of iron replacement...